• Allergan, Gedeon’s fibroid drug hits PhIII targets pharmatimes
    January 19, 2017
    Allergan and Gedeon Richter are gearing up to file ulipristal acetate in the US in the second half of this year, in the hope of securing approval for the first oral treatment option for women suffering from uterine fibroids in the country.
PharmaSources Customer Service